LCM

Lynx1 Capital Management Portfolio holdings

AUM $494M
1-Year Est. Return 143.06%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+143.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$111M
AUM Growth
-$6.52M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
12
New
Increased
Reduced
Closed

Top Buys

1
+$9.31M
2
+$4.59M
3
+$2M
4
JBIO
Jade Biosciences
JBIO
+$1.62M
5
PVLA
Palvella Therapeutics
PVLA
+$470K

Top Sells

1
+$9.26M
2
+$4.78M
3
+$948K
4
IMUX icon
Immunic
IMUX
+$134K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$25.2M 22.69%
2,382,127
-449,461
2
$22M 19.85%
3,056,420
+1,129,551
3
$20M 18.05%
1,674,677
4
$12.3M 11.08%
613,071
-388,146
5
$8.14M 7.34%
2,325,833
-263,846
6
$4.58M 4.13%
7,898
+2,425
7
$4.21M 3.8%
2,275,732
+95,172
8
$4.04M 3.65%
43,939
+3,647
9
$3.44M 3.1%
137,621
+116,550
10
$3.39M 3.06%
1,072,288
-31,953
11
$2.93M 2.64%
504,862
12
$682K 0.62%
2,312,880
+2,282,880